Medical Devices UK

UK Heart Failure Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UK Heart Failure Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $336.1 Mn Placeholder estimate
Estimate 2025 $355.3 Mn 2.8% of the global market
Projected 2034 $585.1 Mn 64.7% Adds $229.8 Mn over 9 forecast years
CAGR 2025–2034 5.7% Faster than 40% of 173 Medical Devices markets here
Key players 5
  • UK is 2.77% of the global market.
  • In Europe, the largest is Germany at $416.6 Mn.
  • Fastest growing: Russia at 8.5% a year.
  • UK ranks 3rd of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$229.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Heart Failure Devices Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $336.1 Mn — —
2025 (base) $355.3 Mn +$19.2 Mn —
2026 (forecast) $375.5 Mn +$20.3 Mn +5.7%
2027 (forecast) $396.9 Mn +$21.4 Mn +11.7%
2028 (forecast) $419.6 Mn +$22.6 Mn +18.1%
2029 (forecast) $443.5 Mn +$23.9 Mn +24.8%
2030 (forecast) $468.8 Mn +$25.3 Mn +31.9%
2031 (forecast) $495.5 Mn +$26.7 Mn +39.5%
2032 (forecast) $523.7 Mn +$28.2 Mn +47.4%
2033 (forecast) $553.6 Mn +$29.9 Mn +55.8%
2034 (forecast) $585.1 Mn +$31.6 Mn +64.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UK Heart Failure Devices Market Analysis at a glance
Market size, 2025$355.3 Mn placeholder estimate
Forecast, 2034$585.1 Mn placeholder estimate
Growth (CAGR), 2025–20345.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDevice, use and end user (see all)
Key playersAbbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson), Impulse Dynamics (see all)
Regulator in the UKMHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
Active clinical trials5 in the UKSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UK Heart Failure Devices Market Analysis Executive Summary

Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.

Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).

Bar chart: UK Heart Failure Devices market size, 2024–2034, placeholder estimates. $336.1 Mn in 2024, $355.3 Mn in 2025 and $585.1 Mn in 2034, 5.7% CAGR.
UK Heart Failure Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UK Heart Failure Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.

Competitive Landscape for Heart Failure Devices Market in UK

The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Heart Failure Devices Market in UK

Heart Failure Devices in the UK: rules, payment and research

Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA).⁠[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.⁠[2] ClinicalTrials.gov lists 5 studies on Heart Failure Devices that are recruiting, active or about to start in the UK.⁠[3] Early deaths from long-term diseases: 10.9% in 2023, the latest WHO figure for the UK.⁠[4]

[1] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[2] National Institute for Health and Care Excellence. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UK.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Heart Failure Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Heart Failure Devices in context

The UK compared

  • Early deaths from long-term diseases: 10.9% (2023). World: 17.2% (2023). 3rd highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 6 countries we cover in Europe.[2]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 6 countries we cover in Europe.[3]

[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Heart Failure Devices market in the UK?
Placeholder estimate: about $355.3 Mn in 2025, rising to about $585.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Heart Failure Devices market in the UK growing?
Placeholder estimate: about 5.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Heart Failure Devices market report cover?
The report splits the market by device (Ventricular Assist Devices, CRT Devices, ICDs, Implantable Monitors), use (Bridge to Transplant, Destination Therapy, Monitoring) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Heart Failure Devices market?
Key players include Abbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson) and Impulse Dynamics.
What is driving the Heart Failure Devices market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.
Who regulates Heart Failure Devices in the UK?
Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA). Source: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in the UK?
The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund. Source: National Institute for Health and Care Excellence. Checked 14 Nov 2026.
How many clinical trials on Heart Failure Devices are running in the UK?
5 studies are recruiting, active or about to start in the UK, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.
What does WHO report for the UK?
Early deaths from long-term diseases: 10.9% in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
How many people in the UK are 65 or older?
19.7% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 16 Nov 2026.
Back to Catalogue

Related Medical Devices reports in UK

See all

Related on cardiovascular

See the topic